Literature DB >> 20026128

Excision of titin's cardiac PEVK spring element abolishes PKCalpha-induced increases in myocardial stiffness.

Bryan D Hudson1, Carlos G Hidalgo, Michael Gotthardt, Henk L Granzier.   

Abstract

Protein kinase C-alpha (PKCalpha) was recently reported to increase myocardial stiffness, an effect that was proposed to be due to phosphorylation of two highly conserved sites (S11878 and S12022) within the proline-glutamic acid-valine-lysine (PEVK) rich spring element of titin. To test this proposal we investigated the effect of PKCalpha on phosphorylation and passive stiffness in a mouse model lacking the titin exons that contain these two phosphorylation sites, the PEVK knockout (KO). We used skinned, gelsolin-extracted, left ventricular myocardium from wildtype and PEVK KO mice. Consistent with previous work we found that PKCalpha increased passive stiffness in the WT myocardium by 27+/-6%. Importantly, this effect was completely abolished in KO myocardium. In addition, increases in the elastic and viscous moduli at a wide range of frequencies (properties important in diastolic filling) following PKCalpha incubation (27+/-3% and 20+/-4%, respectively) were also ablated in the KO. Back phosphorylation assays showed that titin phosphorylation following incubation with PKCalpha was significantly reduced by 36+/-12% in skinned PEVK KO myocardial tissues. The remaining phosphorylation in the KO suggests that PKCalpha sites exist in the titin molecule outside the PEVK region; these sites are not involved in increasing passive stiffness. Our results firmly support that the PEVK region of cardiac titin is phosphorylated by PKCalpha and that this increases passive tension. Thus, the PEVK spring element is the critical site of PKCalpha's involvement in passive myocardial stiffness. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20026128      PMCID: PMC2854275          DOI: 10.1016/j.yjmcc.2009.12.006

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  48 in total

1.  Changes in titin and collagen underlie diastolic stiffness diversity of cardiac muscle.

Authors:  Y Wu; O Cazorla; D Labeit; S Labeit; H Granzier
Journal:  J Mol Cell Cardiol       Date:  2000-12       Impact factor: 5.000

Review 2.  Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation.

Authors:  Joseph M Metzger; Margaret V Westfall
Journal:  Circ Res       Date:  2004-02-06       Impact factor: 17.367

3.  Alterations in protein kinase C isoenzyme expression and autophosphorylation during the progression of pressure overload-induced left ventricular hypertrophy.

Authors:  Allison L Bayer; Maria C Heidkamp; Nehu Patel; Michael Porter; Steve Engman; Allen M Samarel
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

4.  Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium.

Authors:  Attila Borbély; Ines Falcao-Pires; Loek van Heerebeek; Nazha Hamdani; István Edes; Cristina Gavina; Adelino F Leite-Moreira; Jean G F Bronzwaer; Zoltán Papp; Jolanda van der Velden; Ger J M Stienen; Walter J Paulus
Journal:  Circ Res       Date:  2009-01-29       Impact factor: 17.367

5.  Changes in titin isoform expression in pacing-induced cardiac failure give rise to increased passive muscle stiffness.

Authors:  Yiming Wu; Stephen P Bell; Karoly Trombitas; Christian C Witt; Siegfried Labeit; Martin M LeWinter; Henk Granzier
Journal:  Circulation       Date:  2002-09-10       Impact factor: 29.690

Review 6.  The giant protein titin: a major player in myocardial mechanics, signaling, and disease.

Authors:  Henk L Granzier; Siegfried Labeit
Journal:  Circ Res       Date:  2004-02-20       Impact factor: 17.367

7.  Species variations in cDNA sequence and exon splicing patterns in the extensible I-band region of cardiac titin: relation to passive tension.

Authors:  Marion L Greaser; Mustapha Berri; Chad M Warren; Paul E Mozdziak
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

8.  Increased expression of protein kinase C isoforms in heart failure due to myocardial infarction.

Authors:  Jingwei Wang; Xueliang Liu; Emmanuelle Sentex; Nobuakira Takeda; Naranjan S Dhalla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-06       Impact factor: 4.733

9.  Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium.

Authors:  YeQing Pi; Dahua Zhang; Kara R Kemnitz; Hao Wang; Jeffery W Walker
Journal:  J Physiol       Date:  2003-08-15       Impact factor: 5.182

10.  Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes.

Authors:  R Yamasaki; Y Wu; M McNabb; M Greaser; S Labeit; H Granzier
Journal:  Circ Res       Date:  2002-06-14       Impact factor: 17.367

View more
  25 in total

1.  Activation and stretch-induced passive force enhancement--are you pulling my chain? Focus on "Regulation of muscle force in the absence of actin-myosin-based cross-bridge interaction".

Authors:  Henk L Granzier
Journal:  Am J Physiol Cell Physiol       Date:  2010-05-05       Impact factor: 4.249

2.  Hyperphosphorylation of mouse cardiac titin contributes to transverse aortic constriction-induced diastolic dysfunction.

Authors:  Bryan Hudson; Carlos Hidalgo; Chandra Saripalli; Henk Granzier
Journal:  Circ Res       Date:  2011-08-11       Impact factor: 17.367

3.  Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction.

Authors:  Mei Methawasin; Joshua G Strom; Rebecca E Slater; Vanessa Fernandez; Chandra Saripalli; Henk Granzier
Journal:  Circulation       Date:  2016-09-14       Impact factor: 29.690

Review 4.  Titin is a major human disease gene.

Authors:  Martin M LeWinter; Henk L Granzier
Journal:  Circulation       Date:  2013-02-26       Impact factor: 29.690

5.  Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.

Authors:  Michael R Zile; Catalin F Baicu; John S Ikonomidis; Robert E Stroud; Paul J Nietert; Amy D Bradshaw; Rebecca Slater; Bradley M Palmer; Peter Van Buren; Markus Meyer; Margaret M Redfield; David A Bull; Henk L Granzier; Martin M LeWinter
Journal:  Circulation       Date:  2015-01-30       Impact factor: 29.690

6.  Cell-intrinsic functional effects of the α-cardiac myosin Arg-403-Gln mutation in familial hypertrophic cardiomyopathy.

Authors:  Peiying Chuan; Sivaraj Sivaramakrishnan; Euan A Ashley; James A Spudich
Journal:  Biophys J       Date:  2012-06-19       Impact factor: 4.033

7.  Titin based viscosity in ventricular physiology: an integrative investigation of PEVK-actin interactions.

Authors:  Charles S Chung; Methajit Methawasin; O Lynne Nelson; Michael H Radke; Carlos G Hidalgo; Michael Gotthardt; Henk L Granzier
Journal:  J Mol Cell Cardiol       Date:  2011-06-16       Impact factor: 5.000

8.  The multifunctional Ca(2+)/calmodulin-dependent protein kinase II delta (CaMKIIδ) phosphorylates cardiac titin's spring elements.

Authors:  Carlos G Hidalgo; Charles S Chung; Chandra Saripalli; Mei Methawasin; Kirk R Hutchinson; George Tsaprailis; Siegfried Labeit; Alicia Mattiazzi; Henk L Granzier
Journal:  J Mol Cell Cardiol       Date:  2012-12-05       Impact factor: 5.000

9.  Physiologic basis and pathophysiologic implications of the diastolic properties of the cardiac muscle.

Authors:  João Ferreira-Martins; Adelino F Leite-Moreira
Journal:  J Biomed Biotechnol       Date:  2010-06-02

10.  Shortening of the elastic tandem immunoglobulin segment of titin leads to diastolic dysfunction.

Authors:  Charles S Chung; Kirk R Hutchinson; Mei Methawasin; Chandra Saripalli; John E Smith; Carlos G Hidalgo; Xiuju Luo; Siegfried Labeit; Caiying Guo; Henk L Granzier
Journal:  Circulation       Date:  2013-05-24       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.